'Evolution-proofing' antibacterials
- PMID: 25125554
- PMCID: PMC4202175
- DOI: 10.1093/emph/eou020
'Evolution-proofing' antibacterials
Similar articles
-
Genomic vulnerability of a dominant seaweed points to future-proofing pathways for Australia's underwater forests.Glob Chang Biol. 2021 May;27(10):2200-2212. doi: 10.1111/gcb.15534. Epub 2021 Feb 16. Glob Chang Biol. 2021. PMID: 33511779
-
Fatigue proofing: The role of protective behaviours in mediating fatigue-related risk in a defence aviation environment.Accid Anal Prev. 2017 Feb;99(Pt B):465-468. doi: 10.1016/j.aap.2015.10.011. Epub 2015 Nov 6. Accid Anal Prev. 2017. PMID: 26555252
-
[Understanding mistake-proofing].Ann Fr Anesth Reanim. 2011 Jan;30(1):51-6. doi: 10.1016/j.annfar.2010.10.014. Epub 2010 Dec 10. Ann Fr Anesth Reanim. 2011. PMID: 21146351 French.
-
Fatigue-proofing: a new approach to reducing fatigue-related risk using the principles of error management.Sleep Med Rev. 2012 Apr;16(2):167-75. doi: 10.1016/j.smrv.2011.05.004. Epub 2011 Jul 23. Sleep Med Rev. 2012. PMID: 21784677 Review.
-
Antibacterial therapy for acne: a guide to selection and use of systemic agents.Am J Clin Dermatol. 2003;4(5):307-14. doi: 10.2165/00128071-200304050-00002. Am J Clin Dermatol. 2003. PMID: 12688836 Review.
Cited by
-
Manipulating virulence factor availability can have complex consequences for infections.Evol Appl. 2016 Oct 24;10(1):91-101. doi: 10.1111/eva.12431. eCollection 2017 Jan. Evol Appl. 2016. PMID: 28035238 Free PMC article.
-
High potency of sequential therapy with only β-lactam antibiotics.Elife. 2021 Jul 28;10:e68876. doi: 10.7554/eLife.68876. Elife. 2021. PMID: 34318749 Free PMC article.
-
Tailocin-Mediated Interactions Among Soft Rot Pectobacteriaceae.Mol Ecol. 2025 Apr;34(8):e17728. doi: 10.1111/mec.17728. Epub 2025 Mar 15. Mol Ecol. 2025. PMID: 40087984 Free PMC article.
-
Flexible Fragment Growing Boosts Potency of Quorum-Sensing Inhibitors against Pseudomonas aeruginosa Virulence.ChemMedChem. 2020 Jan 17;15(2):188-194. doi: 10.1002/cmdc.201900621. Epub 2019 Nov 28. ChemMedChem. 2020. PMID: 31709767 Free PMC article.
-
Antivirulence DsbA inhibitors attenuate Salmonella enterica serovar Typhimurium fitness without detectable resistance.FASEB Bioadv. 2021 Feb 10;3(4):231-242. doi: 10.1096/fba.2020-00100. eCollection 2021 Apr. FASEB Bioadv. 2021. PMID: 33842848 Free PMC article.
References
-
- Burnet M. Natural History of Infectious Disease. Cambridge University Press; 1962.
-
- Clatworthy AE, Pierson E, Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol. 2007;3:541–8. - PubMed
-
- WHO. Antimicrobial Resistance: Global Report on Surveillance, 2014.
-
- Allen RC, Popat R, Diggle SP, et al. Targeting virulence: can we make evolution-proof drugs? Nat Rev Microbiol. 2014;12:300–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources